Norma I. Rodriguez-Malave
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Norma I. Rodriguez-Malave has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- David Casero
F. Widjaja Inflammatory Bowel Disease Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
3 shared publications - Dinesh S. Rao
Department of Pathology and Laboratory Medicine, University of California , Los Angeles, CA 90095
3 shared publications - Ella Waters
Affiliation School of Life, Health and Chemical Sciences, The Open University, Walton Hall, Milton Keynes, United Kingdom
3 shared publications - Giuseppe Basso
University of Padua
3 shared publications - Martina Pigazzi
Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Women’s and Children’s Health, University of Padova, Padova, Italy
3 shared publications Thilini R. Fernando
3 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Figures 1-7 from LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia
Supplemental Figures 1-7. Supplemental Figure 1: Schematic depiction of the pipeline to determine pathophysiologically important lncRNAs. Supplemental Figure 2: LncRNA expression can predict the cytogenetic subtype of B-ALL. Supplemental Figure 3: Two step cluster analysis identified two clusters of expressors. Supplemental Figure 4: LncRNA positional information and molecular characterization of BALR-2. Supplemental Figure 5: BALR-2 has an expression pattern similar to known glucocorticoid genes. Supplemental Figure 6: Critical glucocorticoid responsive genes show altered expression after knockdown of BALR-2 in leukemic cell lines, mirroring the effects of glucocorticoid receptor engagement. Supplemental Figure 7: Proposed mechanism of action of BALR-2 in the glucocorticoid response pathway.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figures 1-7 from LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia
Supplemental Figures 1-7. Supplemental Figure 1: Schematic depiction of the pipeline to determine pathophysiologically important lncRNAs. Supplemental Figure 2: LncRNA expression can predict the cytogenetic subtype of B-ALL. Supplemental Figure 3: Two step cluster analysis identified two clusters of expressors. Supplemental Figure 4: LncRNA positional information and molecular characterization of BALR-2. Supplemental Figure 5: BALR-2 has an expression pattern similar to known glucocorticoid genes. Supplemental Figure 6: Critical glucocorticoid responsive genes show altered expression after knockdown of BALR-2 in leukemic cell lines, mirroring the effects of glucocorticoid receptor engagement. Supplemental Figure 7: Proposed mechanism of action of BALR-2 in the glucocorticoid response pathway.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Information from LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia
Supplemental Information. Additional Methods and Supplemental Figure Legends
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Information from LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia
Supplemental Information. Additional Methods and Supplemental Figure Legends
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplemental Tables 1 - 4 from LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia
Supplemental Tables 1 - 4. Supplemental Table 1: Patient characteristics for use in this study. Supplemental Table 2: Correlational bivariate analyses between ordinal variable clinicopathologic characteristics. Supplemental Table 3: Results of Cox Regression analysis using BALR-2, Translocation, and Prednisone Response as co-variates.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Tables 1 - 4 from LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia
Supplemental Tables 1 - 4. Supplemental Table 1: Patient characteristics for use in this study. Supplemental Table 2: Correlational bivariate analyses between ordinal variable clinicopathologic characteristics. Supplemental Table 3: Results of Cox Regression analysis using BALR-2, Translocation, and Prednisone Response as co-variates.
- Open Access
pumilio regulates sleep homeostasis in response to chronic sleep deprivation in Drosophila melanogaster
Recent studies have identified the Drosophila brain circuits involved in the sleep/wake switch and have pointed to the modulation of neuronal excitability as one of the underlying mechanisms triggering sleep need. In this study we aimed to explore the link between the homeostatic regulation of neuronal excitability and sleep behavior in the circadian circuit. For this purpose, we selected the neuronal homeostasis protein Pumilio (Pum), whose main function is to repress protein translation and has been linked to modulation of neuronal excitability during chronic patterns of altered neuronal activity. Here we explore the effects of Pum on sleep homeostasis in Drosophila melanogaster , which shares most of the major features of mammalian sleep homeostasis. Our evidence indicates that Pum is necessary for sleep rebound and that its effect is more pronounced during chronic sleep deprivation (84 hours) than acute deprivation (12 hours). Knockdown of pum , results in a reduction of sleep rebound during acute sleep deprivation and the complete abolishment of sleep rebound during chronic sleep deprivation. These behavioral changes were associated with accompanying changes in the expression of genes involved in the regulation of neuronal excitability. Interestingly, pum knockdown also increased baseline daytime sleep, suggesting that Pum differentially regulates rebound and normal sleep. Based on these findings, we propose that Pum is a critical regulator of sleep homeostasis through neural adaptations triggered during sleep deprivation and induces rebound sleep by altering neuronal excitability.
Open Accesspumilio regulates sleep homeostasis in response to chronic sleep deprivation in Drosophila melanogaster
Recent studies have identified the Drosophila brain circuits involved in the sleep/wake switch and have pointed to the modulation of neuronal excitability as one of the underlying mechanisms triggering sleep need. In this study we aimed to explore the link between the homeostatic regulation of neuronal excitability and sleep behavior in the circadian circuit. For this purpose, we selected the neuronal homeostasis protein Pumilio (Pum), whose main function is to repress protein translation and has been linked to modulation of neuronal excitability during chronic patterns of altered neuronal activity. Here we explore the effects of Pum on sleep homeostasis in Drosophila melanogaster , which shares most of the major features of mammalian sleep homeostasis. Our evidence indicates that Pum is necessary for sleep rebound and that its effect is more pronounced during chronic sleep deprivation (84 hours) than acute deprivation (12 hours). Knockdown of pum , results in a reduction of sleep rebound during acute sleep deprivation and the complete abolishment of sleep rebound during chronic sleep deprivation. These behavioral changes were associated with accompanying changes in the expression of genes involved in the regulation of neuronal excitability. Interestingly, pum knockdown also increased baseline daytime sleep, suggesting that Pum differentially regulates rebound and normal sleep. Based on these findings, we propose that Pum is a critical regulator of sleep homeostasis through neural adaptations triggered during sleep deprivation and induces rebound sleep by altering neuronal excitability.
- 22 December 2018
- Published by Taylor & Francis in Gut Microbes
- Vol. 10 (4) , 458-480
A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period
Probiotics are considered to have multiple beneficial effects on the human gastrointestinal tract, including immunomodulation, pathogen inhibition, and improved host nutrient metabolism. However, extensive characterization of these properties is needed to define suitable clinical applications for probiotic candidates. Lactobacillus johnsonii 456 (LBJ 456) was previously demonstrated to have anti-inflammatory and anti-genotoxic effects in a mouse model. Here, we characterize its resistance to gastric and bile acids as well as its ability to inhibit gut pathogens and adhere to host mucosa. While bile resistance and in vitro host attachment properties of LBJ 456 were comparable to other tested probiotics, LBJ 456 maintained higher viability at lower pH conditions compared to other tested strains. LBJ 456 also altered pathogen adhesion to LS 174T monolayers and demonstrated contact-dependent and independent inhibition of pathogen growth. Genome analyses further revealed possible genetic elements involved in host attachment and pathogen inhibition. Importantly, we show that ingestion of Lactobacillus johnsonii 456 over a one week yogurt course leads to persistent viable bacteria detectable even beyond the period of initial ingestion, unlike many other previously described probiotic species of lactic acid bacteria.
- 22 December 2018
- Published by Taylor & Francis in Gut Microbes
- Vol. 10 (4) , 458-480
A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period
Probiotics are considered to have multiple beneficial effects on the human gastrointestinal tract, including immunomodulation, pathogen inhibition, and improved host nutrient metabolism. However, extensive characterization of these properties is needed to define suitable clinical applications for probiotic candidates. Lactobacillus johnsonii 456 (LBJ 456) was previously demonstrated to have anti-inflammatory and anti-genotoxic effects in a mouse model. Here, we characterize its resistance to gastric and bile acids as well as its ability to inhibit gut pathogens and adhere to host mucosa. While bile resistance and in vitro host attachment properties of LBJ 456 were comparable to other tested probiotics, LBJ 456 maintained higher viability at lower pH conditions compared to other tested strains. LBJ 456 also altered pathogen adhesion to LS 174T monolayers and demonstrated contact-dependent and independent inhibition of pathogen growth. Genome analyses further revealed possible genetic elements involved in host attachment and pathogen inhibition. Importantly, we show that ingestion of Lactobacillus johnsonii 456 over a one week yogurt course leads to persistent viable bacteria detectable even beyond the period of initial ingestion, unlike many other previously described probiotic species of lactic acid bacteria.